23:08:09 EDT Sun 19 May 2024
Enter Symbol
or Name

Z:DHR - DANAHER CORP - http://www.danaher.com
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
DHR - Z0.3265.50·266.000.5265.80+1.000.43,187.4841,33323,239265.03  265.94  263.18265.365  182.0919:50:14May 0915 min RT 2¢

Recent Trades - Last 10 of 23239
Time ETExPriceChangeVolume

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2024-05-09 07:00U:DHRNews ReleaseDanaher Launches Collaboration with Johns Hopkins University Aiming to Improve Neurological Diagnosis
2024-05-07 16:45U:DHRNews ReleaseDanaher to Present at Bank of America Securities Healthcare Conference
2024-05-07 16:15U:DHRNews ReleaseDanaher Announces Quarterly Dividend
2024-05-03 09:06U:DHRNews ReleaseCuriox Biosystems and Beckman Coulter Life Sciences Announce a Partnership Combining C-FREE(TM) Technology with DURA Innovations for Hands-Free Washed Sample Preparation for Flow Cytometry
2024-04-23 06:00U:DHRNews ReleaseDanaher Reports First Quarter 2024 Results
2024-03-21 16:15U:DHRNews ReleaseDanaher Schedules First Quarter 2024 Earnings Conference Call
2024-02-27 16:15U:DHRNews ReleaseDanaher to Present at TD Cowen Health Care Conference
2024-02-22 16:15U:DHRNews ReleaseDanaher Commits to Set Science-Based, Net-Zero Greenhouse Gas Emission Reduction Targets
2024-02-21 16:15U:DHRNews ReleaseDanaher Announces Quarterly Dividend
2024-02-05 07:30U:DHRNews ReleaseDanaher Launches Collaboration with Cincinnati Children's Hospital Medical Center Aiming to Improve Patient Safety in Early Drug Development
2024-01-30 06:00U:DHRNews ReleaseDanaher Reports Fourth Quarter and Full Year 2023 Results
2024-01-09 07:30U:DHRNews ReleaseDanaher, Jennifer Doudna, and Innovative Genomics Institute Launch Danaher-IGI Beacon for CRISPR Cures with Aim to Address Hundreds of Diseases Using Gene-editing Platform Solution
2024-01-08 16:15U:DHRNews ReleaseDanaher CEO to Comment on Financial Performance
2024-01-02 17:00U:DHRNews ReleaseDanaher to Present at J.P. Morgan Healthcare Conference
2023-12-21 16:30U:DHRNews ReleaseDanaher Schedules Fourth Quarter 2023 Earnings Conference Call
2023-12-13 16:06U:DHRNews ReleaseCodexis and Aldevron Enter Exclusive Licensing Agreement for Codex ‚ ® HiCap RNA Polymerase
2023-12-06 07:30U:DHRNews ReleaseDanaher Completes Acquisition of Abcam
2023-12-05 16:30U:DHRNews ReleaseDanaher Announces Quarterly Dividend
2023-11-21 16:15U:DHRNews ReleaseDanaher to Present at Evercore ISI HealthCONx Conference
2023-10-31 07:30U:DHRNews ReleaseDanaher appoints Christopher Riley to Executive Vice President for Biotechnology